Contact us

Support


Home > Investment tools > They choose Russia > F. Hoffmann-La Roche Ltd

F. Hoffmann-La Roche Ltd

The Russian Pharmstandard pharmaceutical company and Swiss Roche plans to localize the manufacture of Gaziva preparation for chronic lymphocytic leukemia and follicular lymphoma at the Pharmstandard-UfaVITA plant in the Republic of Bashkortostan. The relevant memorandum of intent was signed by the parties during a press conference.

The companies also intend to export drugs produced in Russia.

31 August 2017
RIA Novosti
Investor
84.7 mln
Moscow

Investor profile

F. Hoffmann-La Roche Ltd

Switzerland

Company's website: http://www.roche.com

T: +41 61 688 1111

A public company

Contact: Severin Schwan, General Director

Roche Holding is a holding company for Roche, a group of pharmaceutical companies. The group is based on F. Hoffmann-La Roche, a Swiss pharmaceutical company, one of the world’s leading companies in the field of pharmaceuticals and diagnostics.

Subscribe to Newsletters

Email: